1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine

C182H256B4Br3ClI2N30O18 — CID 158071669

About 1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine

1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine (PubChem CID 158071669) has the molecular formula C182H256B4Br3ClI2N30O18 and a molecular weight of 3724.46 g/mol. Its IUPAC name is 1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine.

Molecular Properties

• Compound Name: 1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine
• PubChem CID: 158071669
• Molecular Formula: C182H256B4Br3ClI2N30O18
• Molecular Weight: 3724.46 g/mol
• Exact Mass: 3719.57
• IUPAC Name: 1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine
• SMILES: CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2cnn(C3CCCCO3)c2)OC1(C)C.CN(c1ccc(-c2ccc(-c3cn[nH]c3)cc2O)nn1)C1C[C@]2(C)CCC[C@](C)(C1)N2.CNC1C[C@]2(C)CC[C@](C)(C1)N2.CNC1C[C@]2(C)CC[C@](C)(C1)N2.COc1cc(-c2cnn(C3CCCCO3)c2)ccc1B1OC(C)(C)C(C)(C)O1.COc1cc(-c2cnn(C3CCCCO3)c2)ccc1Br.COc1cc(I)ccc1Br.C[C@]12CC[C@](C)(CC(N)C1)N2.Cc1cc(-c2cnn(C3CCCCO3)c2)ccc1-c1ccc(N(C)C2C[C@]3(C)CC[C@](C)(C2)N3)nn1.Cc1ccc(-c2ccc(-c3cnn(C4CCCCO4)c3)cc2C)nn1.Cc1ccc(Cl)nn1.Oc1cc(I)ccc1Br
• InChI: InChI=1S/C29H38N6O.C24H30N6O.C21H29BN2O4.C20H22N4O.C15H17BrN2O2.C14H23BN2O3.C12H24B2O4.2C10H20N2.C9H18N2.C7H6BrIO.C6H4BrIO.C5H5ClN2/c1-20-15-21(22-18-30-35(19-22)27-7-5-6-14-36-27)8-9-24(20)25-10-11-26(32-31-25)34(4)23-16-28(2)12-13-29(3,17-23)33-28;1-23-9-4-10-24(2,29-23)13-18(12-23)30(3)22-8-7-20(27-28-22)19-6-5-16(11-21(19)31)17-14-25-26-15-17;1-20(2)21(3,4)28-22(27-20)17-10-9-15(12-18(17)25-5)16-13-23-24(14-16)19-8-6-7-11-26-19;1-14-11-16(7-8-18(14)19-9-6-15(2)22-23-19)17-12-21-24(13-17)20-5-3-4-10-25-20;1-19-14-8-11(5-6-13(14)16)12-9-17-18(10-12)15-4-2-3-7-20-15;1-13(2)14(3,4)20-15(19-13)11-9-16-17(10-11)12-7-5-6-8-18-12;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;2*1-9-4-5-10(2,12-9)7-8(6-9)11-3;1-8-3-4-9(2,11-8)6-7(10)5-8;1-10-7-4-5(9)2-3-6(7)8;7-5-2-1-4(8)3-6(5)9;1-4-2-3-5(6)8-7-4/h8-11,15,18-19,23,27,33H,5-7,12-14,16-17H2,1-4H3;5-8,11,14-15,18,29,31H,4,9-10,12-13H2,1-3H3,(H,25,26);9-10,12-14,19H,6-8,11H2,1-5H3;6-9,11-13,20H,3-5,10H2,1-2H3;5-6,8-10,15H,2-4,7H2,1H3;9-10,12H,5-8H2,1-4H3;1-8H3;2*8,11-12H,4-7H2,1-3H3;7,11H,3-6,10H2,1-2H3;2-4H,1H3;1-3,9H;2-3H,1H3/t23?,27?,28-,29+;18?,23-,24+;;;;;;2*8?,9-,10+;7?,8-,9+
• InChIKey: FLWVPGBOIFHUIU-IXCMDQBESA-N
• XLogP: 36.48
• TPSA: 525.75 Ų
• H-Bond Donors: 11
• H-Bond Acceptors: 47
• Rotatable Bonds: 25
• Heavy Atoms: 240
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3724.46
LogP ≤ 5	36.48
H-Bond Donors ≤ 5	11
H-Bond Acceptors ≤ 10	47

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine?

The IUPAC name of 1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine (CID 158071669) is 1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine.

What is the SMILES notation for 1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine?

The canonical SMILES for 1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine is CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2cnn(C3CCCCO3)c2)OC1(C)C.CN(c1ccc(-c2ccc(-c3cn[nH]c3)cc2O)nn1)C1C[C@]2(C)CCC[C@](C)(C1)N2.CNC1C[C@]2(C)CC[C@](C)(C1)N2.CNC1C[C@]2(C)CC[C@](C)(C1)N2.COc1cc(-c2cnn(C3CCCCO3)c2)ccc1B1OC(C)(C)C(C)(C)O1.COc1cc(-c2cnn(C3CCCCO3)c2)ccc1Br.COc1cc(I)ccc1Br.C[C@]12CC[C@](C)(CC(N)C1)N2.Cc1cc(-c2cnn(C3CCCCO3)c2)ccc1-c1ccc(N(C)C2C[C@]3(C)CC[C@](C)(C2)N3)nn1.Cc1ccc(-c2ccc(-c3cnn(C4CCCCO4)c3)cc2C)nn1.Cc1ccc(Cl)nn1.Oc1cc(I)ccc1Br.

What is the InChIKey of 1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine?

The InChIKey is FLWVPGBOIFHUIU-IXCMDQBESA-N. The full InChI is InChI=1S/C29H38N6O.C24H30N6O.C21H29BN2O4.C20H22N4O.C15H17BrN2O2.C14H23BN2O3.C12H24B2O4.2C10H20N2.C9H18N2.C7H6BrIO.C6H4BrIO.C5H5ClN2/c1-20-15-21(22-18-30-35(19-22)27-7-5-6-14-36-27)8-9-24(20)25-10-11-26(32-31-25)34(4)23-16-28(2)12-13-29(3,17-23)33-28;1-23-9-4-10-24(2,29-23)13-18(12-23)30(3)22-8-7-20(27-28-22)19-6-5-16(11-21(19)31)17-14-25-26-15-17;1-20(2)21(3,4)28-22(27-20)17-10-9-15(12-18(17)25-5)16-13-23-24(14-16)19-8-6-7-11-26-19;1-14-11-16(7-8-18(14)19-9-6-15(2)22-23-19)17-12-21-24(13-17)20-5-3-4-10-25-20;1-19-14-8-11(5-6-13(14)16)12-9-17-18(10-12)15-4-2-3-7-20-15;1-13(2)14(3,4)20-15(19-13)11-9-16-17(10-11)12-7-5-6-8-18-12;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;2*1-9-4-5-10(2,12-9)7-8(6-9)11-3;1-8-3-4-9(2,11-8)6-7(10)5-8;1-10-7-4-5(9)2-3-6(7)8;7-5-2-1-4(8)3-6(5)9;1-4-2-3-5(6)8-7-4/h8-11,15,18-19,23,27,33H,5-7,12-14,16-17H2,1-4H3;5-8,11,14-15,18,29,31H,4,9-10,12-13H2,1-3H3,(H,25,26);9-10,12-14,19H,6-8,11H2,1-5H3;6-9,11-13,20H,3-5,10H2,1-2H3;5-6,8-10,15H,2-4,7H2,1H3;9-10,12H,5-8H2,1-4H3;1-8H3;2*8,11-12H,4-7H2,1-3H3;7,11H,3-6,10H2,1-2H3;2-4H,1H3;1-3,9H;2-3H,1H3/t23?,27?,28-,29+;18?,23-,24+;;;;;;2*8?,9-,10+;7?,8-,9+;;;.

What are the key properties of 1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine?

1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine has a molecular weight of 3724.46 g/mol, XLogP of 36.48, 25 rotatable bonds, 11 hydrogen bond donors, and 47 hydrogen bond acceptors.

Where does this data come from?

All data for 1-bromo-4-iodo-2-methoxybenzene;2-bromo-5-iodophenol;4-(4-bromo-3-methoxyphenyl)-1-(oxan-2-yl)pyrazole;3-chloro-6-methylpyridazine;2-[6-[[(1S,5R)-1,5-dimethyl-9-azabicyclo[3.3.1]nonan-3-yl]-methylamino]pyridazin-3-yl]-5-(1H-pyrazol-4-yl)phenol;(1S,5R)-1,5-dimethyl-8-azabicyclo[3.2.1]octan-3-amine;4-[3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1-(oxan-2-yl)pyrazole;3-methyl-6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazine;1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;bis((1S,5R)-N,1,5-trimethyl-8-azabicyclo[3.2.1]octan-3-amine);(1S,5R)-N,1,5-trimethyl-N-[6-[2-methyl-4-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]pyridazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine is sourced from PubChem (CID 158071669), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).